Genomictree, Inc. (228760) Ratios

― Followers

Genomictree, Inc. Ratios

KR:228760's free cash flow for Q1 2026 was ₩-1.03. For the 2026 fiscal year, KR:228760's free cash flow was decreased by ₩ and operating cash flow was ₩-7.94. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	60.85	17.75	20.56	18.06	2.21
Quick Ratio	60.59	17.69	20.49	17.96	2.20
Cash Ratio	13.10	3.67	5.55	8.57	1.26
Solvency Ratio	-3.19	-1.46	-1.42	-0.97	-0.09
Operating Cash Flow Ratio	-7.04	-1.63	-2.87	-2.06	0.08
Short-Term Operating Cash Flow Coverage	-285.32	-3.09	-6.91	-6.44	0.15
Net Current Asset Value	₩ 78.69B	₩ 73.45B	₩ 91.31B	₩ 87.56B	₩ 62.65B
Leverage Ratios
Debt-to-Assets Ratio	<0.01	0.02	0.02	0.01	0.18
Debt-to-Equity Ratio	<0.01	0.02	0.02	0.01	0.27
Debt-to-Capital Ratio	<0.01	0.02	0.02	0.01	0.21
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.02	1.05	1.05	1.06	1.52
Debt Service Coverage Ratio	-46.66	-3.84	-3.93	-1.54	0.01
Interest Coverage Ratio	-47.03	-33.42	-51.97	-8.42	1.65
Debt to Market Cap	<0.01	<0.01	<0.01	<0.01	0.16
Interest Debt Per Share	12.22	112.70	100.24	173.66	1.65K
Net Debt to EBITDA	1.32	1.36	2.73	6.93	-12.70
Profitability Margins
Gross Profit Margin	-38.06%	1.95%	-30.76%	-7.90%	83.69%
EBIT Margin	-484.80%	-300.47%	-427.32%	-217.93%	5.65%
EBITDA Margin	-446.94%	-273.34%	-376.61%	-183.47%	10.13%
Operating Profit Margin	-398.40%	-300.47%	-648.24%	-506.24%	29.81%
Pretax Profit Margin	-311.63%	-242.38%	-439.79%	-278.04%	-12.37%
Net Profit Margin	-306.36%	-238.98%	-433.58%	-256.17%	-20.88%
Continuous Operations Profit Margin	-312.06%	-242.68%	-439.84%	-263.51%	-20.88%
Net Income Per EBT	98.31%	98.60%	98.59%	92.14%	168.88%
EBT Per EBIT	78.22%	80.67%	67.84%	54.92%	-41.49%
Return on Assets (ROA)	-7.26%	-7.44%	-7.84%	-6.59%	-3.83%
Return on Equity (ROE)	-7.59%	-7.81%	-8.27%	-7.02%	-5.83%
Return on Capital Employed (ROCE)	-9.54%	-9.71%	-12.16%	-13.56%	8.13%
Return on Invested Capital (ROIC)	-9.54%	-9.52%	-11.97%	-12.68%	6.43%
Return on Tangible Assets	-7.33%	-7.52%	-7.91%	-6.66%	-3.87%
Earnings Yield	-3.13%	-2.18%	-2.51%	-1.73%	-3.38%
Efficiency Ratios
Receivables Turnover	2.35	3.98	3.89	5.07	25.41
Payables Turnover	32.47	47.95	46.18	55.22	36.74
Inventory Turnover	11.72	13.90	9.23	7.43	7.67
Fixed Asset Turnover	0.17	0.19	0.13	0.20	1.67
Asset Turnover	0.02	0.03	0.02	0.03	0.18
Working Capital Turnover Ratio	0.04	0.04	0.03	0.04	0.30
Cash Conversion Cycle	175.33	110.41	125.42	114.56	52.04
Days of Sales Outstanding	155.44	91.76	93.79	72.03	14.36
Days of Inventory Outstanding	31.14	26.27	39.54	49.14	47.61
Days of Payables Outstanding	11.24	7.61	7.90	6.61	9.94
Operating Cycle	186.57	118.02	133.33	121.17	61.98
Cash Flow Ratios
Operating Cash Flow Per Share	-390.70	-301.72	-575.66	-485.87	204.24
Free Cash Flow Per Share	-468.21	-415.27	-683.43	-498.75	117.31
CapEx Per Share	77.52	113.55	107.77	12.88	86.93
Free Cash Flow to Operating Cash Flow	1.20	1.38	1.19	1.03	0.57
Dividend Paid and CapEx Coverage Ratio	-5.04	-2.66	-5.34	-37.73	2.35
Capital Expenditure Coverage Ratio	-5.04	-2.66	-5.34	-37.73	2.35
Operating Cash Flow Coverage Ratio	-213.44	-3.06	-6.56	-5.93	0.15
Operating Cash Flow to Sales Ratio	-3.19	-1.93	-5.77	-3.18	0.14
Free Cash Flow Yield	-3.82%	-2.41%	-3.97%	-2.21%	1.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-32.28	-45.96	-39.77	-57.80	-29.57
Price-to-Sales (P/S) Ratio	100.64	109.82	172.44	148.07	6.18
Price-to-Book (P/B) Ratio	2.39	3.59	3.29	4.06	1.72
Price-to-Free Cash Flow (P/FCF) Ratio	-26.36	-41.42	-25.17	-45.31	74.93
Price-to-Operating Cash Flow Ratio	-30.94	-57.01	-29.88	-46.51	43.04
Price-to-Earnings Growth (PEG) Ratio	25.46	3.41	-3.75	-1.83	0.64
Price-to-Fair Value	2.39	3.59	3.29	4.06	1.72
Enterprise Value Multiple	-21.19	-38.82	-43.06	-73.78	48.30
Enterprise Value	276.89B	398.99B	383.08B	462.67B	146.05B
EV to EBITDA	-21.03	-38.82	-43.06	-73.78	48.30
EV to Sales	93.98	106.11	162.16	135.36	4.89
EV to Free Cash Flow	-24.61	-40.02	-23.67	-41.42	59.34
EV to Operating Cash Flow	-29.50	-55.08	-28.10	-42.52	34.08
Tangible Book Value Per Share	5.02K	4.75K	5.20K	5.52K	5.05K
Shareholders’ Equity Per Share	5.06K	4.79K	5.23K	5.57K	5.10K
Tax and Other Ratios
Effective Tax Rate	>-0.01	>-0.01	>-0.01	0.05	-0.69
Revenue Per Share	122.63	156.62	99.75	152.63	1.42K
Net Income Per Share	-375.69	-374.28	-432.48	-391.00	-297.25
Tax Burden	0.98	0.99	0.99	0.92	1.69
Interest Burden	0.64	0.81	1.03	1.28	-2.19
Research & Development to Revenue	1.12	0.97	2.09	1.28	0.18
SG&A to Revenue	1.15	1.94	1.06	0.85	0.30
Stock-Based Compensation to Revenue	-0.02	0.00	0.82	0.48	<0.01
Income Quality	1.04	0.81	1.31	1.21	-0.69

Currency in KRW